Brief: Neogenomics Announces That Natera Has Voluntarily Withdrawn Its Appeal In Ongoing RaDaR Patent Litigation
15/12/2025 12:24
Dec 15 (Reuters) - Neogenomics Inc NEO.O: NEOGENOMICS ANNOUNCES THAT NATERA HAS VOLUNTARILY WITHDRAWN ITS APPEAL IN ONGOING RADAR PATENT LITIGATION NEOGENOMICS INC - MOVING TOWARD A FULL U.S. CLINICAL LAUNCH OF ITS RADAR ST MOLECULAR RESIDUAL DISEASE (MRD) ASSAY IN Q1 2026 NEOGENOMICS INC - DISMISSAL LEAVES RULING IN NEOGENOMICS' FAVOR Source text: ID:nBw3BVzCQa Further company coverage: NEO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeoGenomics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
NeoGenomics rises after BTIG upgrades to 'buy'
Brief: Neogenomics Announces Executive Leadership And Board Of Directors Succession Plan
Brief: Neogenomics Receives Medicare Coverage For Radar St For Immunotherapy Treatment Response Monitoring